What does CUSIP 45408X308 represent in this 13F holders report?

CUSIP 45408X308 is the security identifier for IGC - IGC Pharma, Inc. - COM NEW used to aggregate holder disclosures.

How many institutions held IGC - IGC Pharma, Inc. - COM NEW in Q2 2019?

23 institutional investors reported IGC - IGC Pharma, Inc. - COM NEW for Q2 2019. Use the holders table for investor-level position and value details.

IGC Pharma, Inc. - COM NEW (IGC)

CUSIP: 45408X308

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class: Equity / COM NEW
Total 13F shares: 1,538,933
Share change: +1,119,736
Total reported value: $2,522,000
Price per share: $1.64
Number of holders: 23
Value change: +$1,830,939
Number of buys: 13
Number of sells: 7

Quarterly Holders Quick Answers

What is CUSIP 45408X308?
CUSIP 45408X308 identifies IGC - IGC Pharma, Inc. - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2019
Previous quarter: Q1 2019

Recent filing periods for CUSIP 45408X308:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of IGC - IGC Pharma, Inc. - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
DEARBORN PARTNERS LLC	13F	Company	— class O/S missing	102,760	$214,000	—	31 Mar 2019	13F
BANK OF MONTREAL /CAN/	13F	Company	— class O/S missing	65,000	$135,000	—	31 Mar 2019	13F
Creative Planning	13F	Company	— class O/S missing	64,039	$133,000	—	31 Mar 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	— class O/S missing	37,380	$78,000	—	31 Mar 2019	13F
SUNTRUST BANKS INC	13F	Company	— class O/S missing	36,667	$76,000	—	31 Mar 2019	13F
MORGAN STANLEY	13F	Company	— class O/S missing	30,150	$63,000	—	31 Mar 2019	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	— class O/S missing	20,750	$43,000	—	31 Mar 2019	13F
Cambridge Investment Research Advisors, Inc.	13F	Company	— class O/S missing	16,540	$34,000	—	31 Mar 2019	13F
TWO SIGMA SECURITIES, LLC	13F	Company	— class O/S missing	14,535	$30,000	—	31 Mar 2019	13F
JANE STREET GROUP, LLC	13F	Company	— class O/S missing	10,971	$23,000	—	31 Mar 2019	13F
UBS Group AG	13F	Company	— class O/S missing	5,727	$12,000	—	31 Mar 2019	13F
SIMPLEX TRADING, LLC	13F	Company	— class O/S missing	4,928	$10,000	—	31 Mar 2019	13F
LADENBURG THALMANN FINANCIAL SERVICES INC.	13F	Company	— class O/S missing	4,300	$9,000	—	31 Mar 2019	13F
Geneos Wealth Management Inc.	13F	Company	— class O/S missing	3,200	$6,000	—	31 Mar 2019	13F
Advisor Group, Inc.	13F	Company	— class O/S missing	1,332	$3,000	—	31 Mar 2019	13F
Financial Architects, Inc	13F	Company	— class O/S missing	1,250	$3,000	—	31 Mar 2019	13F

Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q2 2019

As of 30 Jun 2019, IGC Pharma, Inc. - COM NEW (IGC) was held by 23 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,538,933 shares. The largest 10 holders included VANGUARD GROUP INC, Carroll Financial Associates, Inc., GEODE CAPITAL MANAGEMENT, LLC, DEARBORN PARTNERS LLC, Anson Funds Management LP, Creative Planning, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Virtu Financial LLC, BANK OF MONTREAL /CAN/, and JANE STREET GROUP, LLC. This page lists 23 institutional shareholders reporting positions in this security for the Q2 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders

Q2 2019 holders

Holder diff

Investor	Q1 2019 Shares	Q2 2019 Shares	Share Diff	Share Chg %	Q1 2019 Value $	Q2 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.